Synthesis and characterization of isoliquiritigenin derivatives

Chinese Journal of New Drugs

Volumn 18, Issue 19, 2009, Pages 1882-1885

  Li, Hong Zhi ^a   Mamat, Anwar ^a   Ablise, Mourboul ^a   Niyaz, Ubul ^a   Turdi, Rekiyem ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Chemical synthesis; Hydroxy chalcones (isoliquiritigenin derivatives); Structural characterization; Technology of preparation

Indexed keywords

3' HYDROXY ISOLIQUIRITIGENIN; 3' METHYL ISOLIQUIRITIGENIN; CHALCONE DERIVATIVE; HYDROXYL RADICAL; ISOLIQUIRITIGENIN; UNCLASSIFIED DRUG; VANILLIN;

ARTICLE; CHEMICAL REACTION; DRUG ANALYSIS; DRUG SYNTHESIS; PHYSICAL CHEMISTRY; REACTION TIME; SPECTROMETRY;

EID: 77953379587     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CHOWDHURY SA, KISHINO K, SATOH R. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids[J]. Anticancer Res, 2005,25(3B):2055-2063.
2. HSU YL, KUO PL, LIN CC. Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells[J]. Life Sci, 2005,77(3):279-292. (Pubitemid 40692868)
3. KANAZAWA M, SATOMI Y, MIZUTANI Y, et al. Isoliquiritigenin inhibits the growth of prostate cancer[J]. Eur Urol, 2003,43(5):580-586.
4. ZHANG L, CHEN W, LI X. A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells[J]. FEBS Lett, 2008,582(13):1821-1828.
5. LEE SH, SEO GS, JIN XY, et al. Butein blocks tumor necrosis factor alpha-induced interleukin 8 and matrix metalloproteinase 7 production by inhibiting p38 kinase and osteopontin mediated signaling events in HT-29 cells[J]. Life Sci, 2007,81(21-22):1535-1543.